FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Richard Roden

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Procedures

Neutralization Tests

Anatomy

Co-author Network

Publications

TOP 3
Subhashini Jagu; Kirill Kalnin; Harold Kleanthous; Kihyuck Kwak; Douglas R Lowy; Sudha V Chivukula; Louise T Chow; Warner K Huh; Kilvani S Jaganathan; John T Schiller; Chenguang Wang; Hsu-kun Wang; Richard B S Roden
Phylogenetic considerations in designing a broadly protective multimeric l2 vaccine.
Hirohiko Kamiyama; Mihoko Kamiyama; Balasubramanyam Karanam; Collins A Karikari; Hong Liang; Ming-Tseh Lin; Jun O Liu; Anirban Maitra; Guanglan Mo; Michael Mullendore; Sherri Rauenzahn; Richard B S Roden; F William Schuler; Joong Sup Shim; Georg Feldmann; Manuel Hidalgo; Ralph Hruban; Li Hua; Elizabeth Jaffee; Antonio Jimeno; H A Jinnah; Robert M Beaty; James R Eshleman
Personalized chemotherapy profiling using cancer cell lines from selectable mice.
Joshua W Wang; Richard B S Roden
Virus-like particles for the prevention of human papillomavirus-associated malignancies.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Richard Roden (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Subhashini Jagu; Kirill Kalnin; Harold Kleanthous; Kihyuck Kwak; Douglas R Lowy; Sudha V Chivukula; Louise T Chow; Warner K Huh; Kilvani S Jaganathan; John T Schiller; Chenguang Wang; Hsu-kun Wang; Richard B S Roden
Phylogenetic considerations in designing a broadly protective multimeric l2 vaccine.
Journal of virology 2013;87(11):6127-36.
2013: Hirohiko Kamiyama; Mihoko Kamiyama; Balasubramanyam Karanam; Collins A Karikari; Hong Liang; Ming-Tseh Lin; Jun O Liu; Anirban Maitra; Guanglan Mo; Michael Mullendore; Sherri Rauenzahn; Richard B S Roden; F William Schuler; Joong Sup Shim; Georg Feldmann; Manuel Hidalgo; Ralph Hruban; Li Hua; Elizabeth Jaffee; Antonio Jimeno; H A Jinnah; Robert M Beaty; James R Eshleman
Personalized chemotherapy profiling using cancer cell lines from selectable mice.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(5):1139-46.
2013: Joshua W Wang; Richard B S Roden
Virus-like particles for the prevention of human papillomavirus-associated malignancies.
Expert review of vaccines 2013;12(2):129-41.
2013: Anna V Yemelyanova; Patti Gravitt; Aleksandra Ogurtsova; Brigitte M Ronnett; Ann F Rositch; Jeffrey Seidman; Richard B S Roden
Immunohistochemical detection of human papillomavirus capsid proteins L1 and L2 in squamous intraepithelial lesions: potential utility in diagnosis and management.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2013;26(2):268-74.
2013: Isaac Kinde; Kenneth W Kinzler; Robert J Kurman; Douglas A Levine; Suely Kazue Nagahashi Marie; Nickolas Papadopoulos; Richard B S Roden; Ie-Ming Shih; Bert Vogelstein; Yuxuan Wang; Jian Wu; Nishant Agrawal; Chetan Bettegowda; Jesus Paula Carvalho; Fanny Dao; James R Eshleman; Robert L Giuntoli; Luis Alberto Diaz
Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers.
Science translational medicine 2013;5(167):167ra4.
2013: Kihyuck Kwak; Neil Christensen; Subhashini Jagu; Rosie Jiang; Chenguang Wang; Joshua W Wang; Richard B S Roden
Multivalent human papillomavirus l1 DNA vaccination utilizing electroporation.
PloS one 2013;8(3):e60507.
2013: Subhashini Jagu; Balasubramanyam Karanam; Kihyuck Kwak; Sudha V Chivukula; Vijayarangam Damotharan; Warner K Huh; Richard B S Roden
Optimization of multimeric human papillomavirus L2 vaccines.
PloS one 2013;8(1):e55538.
2012: Alessandra Handisurya; Kihyuck Kwak; Douglas R Lowy; Richard B S Roden; Christopher B Buck; Patricia M Day; Cynthia D Thompson; John T Schiller
Murine skin and vaginal mucosa are similarly susceptible to infection by pseudovirions of different papillomavirus classifications and species.
Virology 2012;433(2):385-94.
2012: Elisabetta Kuhn; Kuan-Tin Kuo; Robert J Kurman; Douglas A Levine; Kentaro Nakayama; Narciso Olvera; Richard B S Roden; Patricia Shaw; Lei Song; Tian-Li Wang; Yue Wang; Lei Wei; Gang Wu; Ren-Chin Wu; Xiguo Yuan; Jinghui Zhang; Blaise Clarke; Bin Guan; Ie-Ming Shih
Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses.
Journal of the National Cancer Institute 2012;104(19):1503-13.
2012: Alex Chang; Ali Amin; Edward Gabrielson; PETER ILLEI; Richard B S Roden; Rajni Sharma; Jonathan I Epstein
Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung.
The American journal of surgical pathology 2012;36(10):1472-6.
2012: Shahan Mamoor; Balasubramanyam Karanam; Lauren Crosby; Richard B S Roden; Kihyuck Kwak; Jennifer Bordeaux; Zeynep Onder; Junona Moroianu
The high risk HPV16 L2 minor capsid protein has multiple transport signals that mediate its nucleocytoplasmic traffic.
Virology 2012;422(2):413-24.
2012: Chien-Fu Hung; Tae Heung Kang; Martin G Pomper; Richard B S Roden; Hsiao-Hsuan Tsai; An-Jen Chiang; Tzyy-choou Wu
Ovarian cancer gene therapy using HPV-16 pseudovirion carrying the HSV-tk gene.
PloS one 2012;7(7):e40983.
2012: Karen Nieto; Mirko Ritter; Richard B S Roden; Sebastian Sedlmeier; Peter Sehr; Hanna Seitz; Margit Weghofer; Lutz Gissmann; Markus Hoerer; Balasubramanyam Karanam; Markus Kellner; Uwe Michaelis; Martin Müller; Jürgen A Kleinschmidt
Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidate.
PloS one 2012;7(6):e39741.
2011: Yuan Tian; Zhihao Yao; Richard B S Roden; HUI ZHANG
Identification of glycoproteins associated with different histological subtypes of ovarian tumors using quantitative glycoproteomics.
Proteomics 2011;11(24):4677-87.
2011: Subhashini Jagu; Kihyuck Kwak; Nicole Malandro; Kenneth E Palmer; M Saveria Campo; Warner K Huh; Richard Schlegel; Hang Yuan; Richard B S Roden
A multimeric L2 vaccine for prevention of animal papillomavirus infections.
Virology 2011;420(1):43-50.
2011: Christopher M Heaphy; Seung-Mo Hong; Christine A Iacobuzio-Donahue; Robert J Kurman; QING KAY LI; Tamara LEVIN Lotan; Anirban Maitra; Elizabeth Montgomery; GEORGES NETTO; Dinesh Rakheja; Richard B S Roden; Ie-Ming Shih; Andrea P Subhawong; Janis M Taube; Luigi Terracciano; Michael Torbenson; William H Westra; Tzyy-choou Wu; Pedram Argani; Angelo M DeMarzo; Charles G Eberhart; Jonathan I Epstein; Edward Gabrielson; Michael Goggins; Alan K Meeker
Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes.
The American journal of pathology 2011;179(4):1608-15.
2011: Dan Lu; Ie-Ming Shih; Robert E Bristow; Robert L Giuntoli; Susanne Krüger Kjaer; Elisabetta Kuhn; Richard B S Roden
Comparison of candidate serologic markers for type I and type II ovarian cancer.
Gynecologic oncology 2011;122(3):560-6.
2011: Barbara Ma; Richard B S Roden; Chien-Fu Hung; Tzyy-choou Wu
HPV pseudovirions as DNA delivery vehicles.
Therapeutic delivery 2011;2(4):427-30.
2011: Kihyuck Kwak; Anna V Yemelyanova; Richard B S Roden
Prevention of cancer by prophylactic human papillomavirus vaccines.
Current opinion in immunology 2011;23(2):244-51.
2011: Martina Bazzaro; RAVI ANCHOORI; Mohana Krishna Mudiam; Olga Issaenko; Srinivas Kumar; Balasubramanyam Karanam; Zhenhua Lin; Rachel Isaksson Vogel; Riccardo Gavioli; Federica Destro; Valeria Ferretti; Richard B S Roden; Saeed R Khan
α,β-Unsaturated carbonyl system of chalcone-based derivatives is responsible for broad inhibition of proteasomal activity and preferential killing of human papilloma virus (HPV) positive cervical cancer cells.
Journal of medicinal chemistry 2011;54(2):449-56.
2011: Moritz Stolla; Lucia Stefanini; Richard B S Roden; Massiel Chavez; Jessica Hirsch; Teshell Greene; Timothy D Ouellette; Sean F Maloney; Scott L Diamond; Mortimer Poncz; Donna S Woulfe; Wolfgang Bergmeier
The kinetics of αIIbβ3 activation determines the size and stability of thrombi in mice: implications for antiplatelet therapy.
Blood 2011;117(3):1005-13.
2011: Wai-Hong Wu; Robert L Garcea; Elizabeth Gersch; Warner K Huh; Subhashini Jagu; Balasubramanyam Karanam; Kihyuck Kwak; Richard B S Roden
Capsomer vaccines protect mice from vaginal challenge with human papillomavirus.
PloS one 2011;6(11):e27141.
2011: RAVI ANCHOORI; Federica Destro; Alicia Felthauser; Riccardo Gavioli; Yoshie Iizuka; Rachel Isaksson Vogel; Saeed R Khan; Shiwen Peng; Richard B S Roden; Thanasak Sueblinvong; Martina Bazzaro
Stressing the ubiquitin-proteasome system without 20S proteolytic inhibition selectively kills cervical cancer cells.
PloS one 2011;6(8):e23888.
2010: Shiwen Peng; A Monie; T H Kang; Chien-Fu Hung; Richard B S Roden; Tzyy-choou Wu
Efficient delivery of DNA vaccines using human papillomavirus pseudovirions.
Gene therapy 2010;17(12):1453-64.
2010: Siân Jones; Tian-Li Wang; Ie-Ming Shih; Tsui-Lien Mao; Kentaro Nakayama; Richard B S Roden; Ruth Glas; Dennis J Slamon; Luis Alberto Diaz; Bert Vogelstein; Kenneth W Kinzler; Victor E Velculescu; Nickolas Papadopoulos
Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma.
Science (New York, N.Y.) 2010;330(6001):228-31.
2010: Balasubramanyam Karanam; Shiwen Peng; Tong Li; Christopher Buck; Patricia M Day; Richard B S Roden
Papillomavirus infection requires gamma secretase.
Journal of virology 2010;84(20):10661-70.
2010: Patricia M Day; Rhonda C Kines; Cynthia D Thompson; Subhashini Jagu; Richard B S Roden; Douglas R Lowy; John T Schiller
In vivo mechanisms of vaccine-induced protection against HPV infection.
Cell host & microbe 2010;8(3):260-70.
2010: Barbara Ma; Richard B S Roden; Tzyy-choou Wu
Current status of human papillomavirus vaccines.
Journal of the Formosan Medical Association = Taiwan yi zhi 2010;109(7):481-3.
2010: Subhashini Jagu; Kihyuck Kwak; Robert L Garcea; Richard B S Roden
Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection.
Vaccine 2010;28(28):4478-86.
2010: S Daayana; E Elkord; U Winters; M Pawlita; Richard B S Roden; Peter L Stern; H C Kitchener
Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia.
British journal of cancer 2010;102(7):1129-36.
2010: M Saveria Campo; Richard B S Roden
Papillomavirus prophylactic vaccines: established successes, new approaches.
Journal of virology 2010;84(3):1214-20.
2009: Kong-Thon Tsen; Shaw-Wei D Tsen; Q Fu; Stuart M Lindsay; Karen Kibler; Bert Jacobs; Tzyy-choou Wu; Balasubramanyam Karanam; Subhashini Jagu; Richard B S Roden; Chien-Fu Hung; Otto F Sankey; B Ramakrishna; Juliann G Kiang
Photonic approach to the selective inactivation of viruses with a near-infrared subpicosecond fiber laser.
Journal of biomedical optics 2009;14(6):064042.
2009: Michael J Conway; Samina Alam; Eric J Ryndock; Linda Cruz; Neil Christensen; Richard B S Roden; Craig Meyers
Tissue-spanning redox gradient-dependent assembly of native human papillomavirus type 16 virions.
Journal of virology 2009;83(20):10515-26.
2009: Christina Schellenbacher; Richard B S Roden; Reinhard Kirnbauer
Chimeric L1-L2 virus-like particles as potential broad-spectrum human papillomavirus vaccines.
Journal of virology 2009;83(19):10085-95.
2009: Miyun Tsai-Turton; Antonio Santillan-Gomez; Dan Lu; Robert E Bristow; Kwun C Chan; Ie-Ming Shih; Richard B S Roden
p53 autoantibodies, cytokine levels and ovarian carcinogenesis.
Gynecologic oncology 2009;114(1):12-7.
2009: Subhashini Jagu; Balasubramanyam Karanam; Ratish Gambhira; Sudha V Chivukula; Revathi J Chaganti; Douglas Lowy; John T Schiller; Richard B S Roden
Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines.
Journal of the National Cancer Institute 2009;101(11):782-92.
2009: Balasubramanyam Karanam; Subhashini Jagu; Warner K Huh; Richard B S Roden
Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infection.
Immunology and cell biology 2009;87(4):287-99.
2009: Balasubramanyam Karanam; Ratish Gambhira; Shiwen Peng; Subhashini Jagu; Dae-Jin Kim; Gary Ketner; Peter L Stern; Robert J Adams; Richard B S Roden
Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunity.
Vaccine 2009;27(7):1040-9.
2009: Zhenhua Lin; Martina Bazzaro; Mei-Cheng Wang; Kwun C Chan; Shiwen Peng; Richard B S Roden
Combination of proteasome and HDAC inhibitors for uterine cervical cancer treatment.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(2):570-7.
2009: Ratish Gambhira; Subhashini Jagu; Balasubramanyam Karanam; Patricia M Day; Richard B S Roden
Role of L2 cysteines in papillomavirus infection and neutralization.
Virology journal 2009;6():176.
2009: Jianghong Li; Cheryl A Sherman-Baust; Miyun Tsai-Turton; Robert E Bristow; Richard B S Roden; Patrice J Morin
Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer.
BMC cancer 2009;9():244.
2009: Zhenhua Lin; Anna V Yemelyanova; Ratish Gambhira; Subhashini Jagu; Craig Meyers; Reinhard Kirnbauer; Brigitte M Ronnett; Patti Gravitt; Richard B S Roden
Expression pattern and subcellular localization of human papillomavirus minor capsid protein L2.
The American journal of pathology 2009;174(1):136-43.
2008: Martina Bazzaro; Zhenhua Lin; Antonio Santillan-Gomez; Michael K Lee; Mei-Cheng Wang; Kwun C Chan; Robert E Bristow; Ralph Mazitschek; James Bradner; Richard B S Roden
Ubiquitin proteasome system stress underlies synergistic killing of ovarian cancer cells by bortezomib and a novel HDAC6 inhibitor.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(22):7340-7.
2008: Warner K Huh; Richard B S Roden
The future of vaccines for cervical cancer.
Gynecologic oncology 2008;109(2 Suppl):S48-56.
2008: Patricia M Day; Ratish Gambhira; Richard B S Roden; Douglas Lowy; John T Schiller
Mechanisms of human papillomavirus type 16 neutralization by l2 cross-neutralizing and l1 type-specific antibodies.
Journal of virology 2008;82(9):4638-46.
2008: Hannah H Alphs; Ratish Gambhira; Balasubramanyam Karanam; Jeffrey N Roberts; Subhashini Jagu; John T Schiller; Weiguang Zeng; David C Jackson; Richard B S Roden
Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(15):5850-5.
2008: Robert J Kurman; Kala Visvanathan; Richard B S Roden; Tzyy-choou Wu; Ie-Ming Shih
Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis.
American journal of obstetrics and gynecology 2008;198(4):351-6.
2008: Chien-Fu Hung; Tzyy-choou Wu; Archana Monie; Richard B S Roden
Antigen-specific immunotherapy of cervical and ovarian cancer.
Immunological reviews 2008;222():43-69.
2008: Archana Monie; Chien-Fu Hung; Richard B S Roden; Tzyy-choou Wu
Cervarix: a vaccine for the prevention of HPV 16, 18-associated cervical cancer.
Biologics : targets & therapy 2008;2(1):97-105.
2008: Richard B S Roden; Patti Gravitt; Tzyy-choou Wu
Towards global prevention of human papillomavirus-induced cancer.
European journal of immunology 2008;38(2):323-6.
2008: Daejin Kim; Ratish Gambhira; Balasubramanyam Karanam; Archana Monie; Chien-Fu Hung; Richard B S Roden; Tzyy-choou Wu
Generation and characterization of a preventive and therapeutic HPV DNA vaccine.
Vaccine 2008;26(3):351-60.
2007: Ratish Gambhira; Balasubramanyam Karanam; Subhashini Jagu; Jeffrey N Roberts; Christopher B Buck; Ioannis Bossis; Hannah Alphs; Timothy D Culp; Neil Christensen; Richard B S Roden
A protective and broadly cross-neutralizing epitope of human papillomavirus L2.
Journal of virology 2007;81(24):13927-31.
2007: Martina Bazzaro; Antonio Santillan-Gomez; Zhenhua Lin; Taylor Tang; Michael K Lee; Robert E Bristow; Ie-Ming Shih; Richard B S Roden
Myosin II co-chaperone general cell UNC-45 overexpression is associated with ovarian cancer, rapid proliferation, and motility.
The American journal of pathology 2007;171(5):1640-9.
2007: Ratish Gambhira; Subhashini Jagu; Balasubramanyam Karanam; Patti Gravitt; Timothy D Culp; Neil Christensen; Richard B S Roden
Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2.
Journal of virology 2007;81(21):11585-92.
2007: Richard B S Roden; Archana Monie; Tzyy-choou Wu
Opportunities to improve the prevention and treatment of cervical cancer.
Current molecular medicine 2007;7(5):490-503.
2007: Rongcun Yang; X Yang; Zhen Zhang; Y Zhang; Shu Wang; Z Cai; Y Jia; Y Ma; C Zheng; Y Lu; Richard B S Roden; Y Chen
Retraction. Single-walled carbon nanotubes-mediated in vivo and in vitro delivery of siRNA into antigen-presenting cells.
Gene therapy 2007;14(11):920.
2007: Abeba Tesfaye; Francescopaolo Di Cello; Joelle Anne Hillion; Brigitte M Ronnett; Ossama Elbahloul; Raheela Ashfaq; Surajit Dhara; Edward Prochownik; Kathryn Tworkoski; Raymond Reeves; Richard B S Roden; Lora Hedrick Ellenson; David L Huso; Linda M. Resar
The high-mobility group A1 gene up-regulates cyclooxygenase 2 expression in uterine tumorigenesis.
Cancer research 2007;67(9):3998-4004.
2007: Michael Berg; Ratish Gambhira; Mark Siracusa; Egbert Hoiczyk; Richard B S Roden; Gary Ketner
HPV16 L1 capsid protein expressed from viable adenovirus recombinants elicits neutralizing antibody in mice.
Vaccine 2007;25(17):3501-10.
2007: Shiwen Peng; Cornelia L Trimble; Lee Wu; Drew M Pardoll; Richard B S Roden; Chien-Fu Hung; Tzyy-choou Wu
HLA-DQB1*02-restricted HPV-16 E7 peptide-specific CD4+ T-cell immune responses correlate with regression of HPV-16-associated high-grade squamous intraepithelial lesions.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(8):2479-87.
2007: Katharina Slupetzky; Ratish Gambhira; Timothy D Culp; Saeed Shafti-Keramat; Christina Schellenbacher; Neil Christensen; Richard B S Roden; Reinhard Kirnbauer
A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11.
Vaccine 2007;25(11):2001-10.
2007: Yen-Yu Lin; Hannah Alphs; Chien-Fu Hung; Richard B S Roden; Tzyy-choou Wu
Vaccines against human papillomavirus.
Frontiers in bioscience : a journal and virtual library 2007;12():246-64.
2006: Ratish Gambhira; Patti Gravitt; Ioannis Bossis; Peter L Stern; Raphael P Viscidi; Richard B S Roden
Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species.
Cancer research 2006;66(23):11120-4.
2006: Rongcun Yang; X Yang; Zhen Zhang; Y Zhang; Shu Wang; Z Cai; Y Jia; Y Ma; C Zheng; Y Lu; Richard B S Roden; Y Chen
Single-walled carbon nanotubes-mediated in vivo and in vitro delivery of siRNA into antigen-presenting cells.
Gene therapy 2006;13(24):1714-23.
2006: Richard B S Roden; Archana Monie; Tzyy-choou Wu
The impact of preventive HPV vaccination.
Discovery medicine 2006;6(35):175-81.
2006: Richard B S Roden; Tzyy-choou Wu
How will HPV vaccines affect cervical cancer?
Nature reviews. Cancer 2006;6(10):753-63.
2006: Ursula Winters; Richard B S Roden; Henry C Kitchener; Peter L Stern
Progress in the development of a cervical cancer vaccine.
Therapeutics and clinical risk management 2006;2(3):259-69.
2006: Zhuohan Zhang; Xiaoying Yang; Yuan Zhang; Bin Zeng; Shujing Wang; Tianhui Zhu; Richard B S Roden; Yongsheng Chen; Rongcun Yang
Delivery of telomerase reverse transcriptase small interfering RNA in complex with positively charged single-walled carbon nanotubes suppresses tumor growth.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(16):4933-9.
2006: Rongcun Yang; Zhong Cai; Yuan Zhang; Wil Yutzy; Katherine F Roby; Richard B S Roden
CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells.
Cancer research 2006;66(13):6807-15.
2006: Martina Bazzaro; Michael K Lee; Alessia Zoso; Wanda L H Stirling; Antonio Santillan-Gomez; Ie-Ming Shih; Richard B S Roden
Ubiquitin-proteasome system stress sensitizes ovarian cancer to proteasome inhibitor-induced apoptosis.
Cancer research 2006;66(7):3754-63.
2006: M Jim Yen; Chih-Yi Hsu; Tsui-Lien Mao; Tzyy-choou Wu; Richard B S Roden; Tian-Li Wang; Ie-Ming Shih
Diffuse mesothelin expression correlates with prolonged patient survival in ovarian serous carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(3 Pt 1):827-31.
2006: Alaattin Erkanli; Douglas D Taylor; Deyrick Dean; Faria Eksir; Daniel Egger; James Geyer; Brad H Nelson; Brad Stone; Herbert A Fritsche; Richard B S Roden
Application of Bayesian modeling of autologous antibody responses against ovarian tumor-associated antigens to cancer detection.
Cancer research 2006;66(3):1792-8.
2005: George Coukos; Tom Li Stephen; Richard B S Roden; Tzyy-choou Wu
Immunotherapy for gynaecological malignancies.
Expert opinion on biological therapy 2005;5(9):1193-210.
2005: Diana V Pastrana; Ratish Gambhira; Christopher B Buck; Yuk-Ying S Pang; Cynthia D Thompson; Timothy D Culp; Neil Christensen; Douglas Lowy; John T Schiller; Richard B S Roden
Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2.
Virology 2005;337(2):365-72.
2005: Cornelia L Trimble; Steven Piantadosi; Patti Gravitt; Brigitte M Ronnett; Ellen S Pizer; Andrea Elko; Barbara Wilgus; William Yutzy; Richard Daniel; Keerti V Shah; Shiwen Peng; Chien-Fu Hung; Richard B S Roden; Tzyy-choou Wu; Drew M Pardoll
Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(13):4717-23.
2005: Rongcun Yang; Francisco Martinez Murillo; Michael J Delannoy; Richard Blosser; Wil Yutzy; Satoshi Uematsu; Kiyoshi Takeda; Shizuo Akira; Raphael P Viscidi; Richard B S Roden
B lymphocyte activation by human papillomavirus-like particles directly induces Ig class switch recombination via TLR4-MyD88.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(12):7912-9.
2005: Rongcun Yang; Cosette M Wheeler; Xiaojiang S Chen; Satoshi Uematsu; Kiyoshi Takeda; Shizuo Akira; Diana V Pastrana; Raphael P Viscidi; Richard B S Roden
Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.
Journal of virology 2005;79(11):6741-50.
2005: Ioannis Bossis; Richard B S Roden; Ratish Gambhira; Rongcun Yang; Mitsuo Tagaya; Peter M Howley; Patricio Ignacio Meneses
Interaction of tSNARE syntaxin 18 with the papillomavirus minor capsid protein mediates infection.
Journal of virology 2005;79(11):6723-31.
2005: Ligia A Pinto; Philip E Castle; Richard B S Roden; Clayton D Harro; Douglas Lowy; John T Schiller; Dora Wallace; Marcus Williams; William Kopp; Ian H Frazer; Jay A Berzofsky; Allan Hildesheim
HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole blood.
Vaccine 2005;23(27):3555-64.
2004: Todd T Tomson; Richard B S Roden; Tzyy-choou Wu
Human papillomavirus vaccines for the prevention and treatment of cervical cancer.
Current opinion in investigational drugs (London, England : 2000) 2004;5(12):1247-61.
2004: Alyson Fay; Wil Yutzy; Richard B S Roden; Junona Moroianu
The positively charged termini of L2 minor capsid protein required for bovine papillomavirus infection function separately in nuclear import and DNA binding.
Journal of virology 2004;78(24):13447-54.
2004: Rongcun Yang; Francisco Martinez Murillo; Hengmi Cui; Richard Blosser; Satoshi Uematsu; Kiyoshi Takeda; Shizuo Akira; Raphael P Viscidi; Richard B S Roden
Papillomavirus-like particles stimulate murine bone marrow-derived dendritic cells to produce alpha interferon and Th1 immune responses via MyD88.
Journal of virology 2004;78(20):11152-60.
2004: Rongcun Yang; Francisco Martinez Murillo; Ken-Yu Lin; Wil Yutzy; Satoshi Uematsu; Kiyoshi Takeda; Shizuo Akira; Raphael P Viscidi; Richard B S Roden
Human papillomavirus type-16 virus-like particles activate complementary defense responses in key dendritic cell subpopulations.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(4):2624-31.
2004: Richard B S Roden; Morris Ling; Tzyy-choou Wu
Vaccination to prevent and treat cervical cancer.
Human pathology 2004;35(8):971-82.
2004: Tae Woo Kim; Jin Hyup Lee; Chien-Fu Hung; Shiwen Peng; Richard B S Roden; Mei-Cheng Wang; Raphael P Viscidi; Ya-Chea Tsai; Liangmei He; Pei-Jer Chen; David A K Boyd; Tzyy-choou Wu
Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus.
Journal of virology 2004;78(9):4638-45.
2003: Richard B S Roden; Tzyy-choou Wu
Preventative and therapeutic vaccines for cervical cancer.
Expert review of vaccines 2003;2(4):495-516.
2003: Brant G Wang; Han-Yao Huang; Yu-Chi Chen; Robert E Bristow; Keyanunoosh Kassauei; Chih-Chien Cheng; Richard B S Roden; Lori J Sokoll; Daniel W Chan; Ie-Ming Shih
Increased plasma DNA integrity in cancer patients.
Cancer research 2003;63(14):3966-8.
2003: Rongcun Yang; Wil Yutzy; Raphael P Viscidi; Richard B S Roden
Interaction of L2 with beta-actin directs intracellular transport of papillomavirus and infection.
The Journal of biological chemistry 2003;278(14):12546-53.
2003: Rongcun Yang; Patricia M Day; Wil Yutzy; Ken-Yu Lin; Chien-Fu Hung; Richard B S Roden
Cell surface-binding motifs of L2 that facilitate papillomavirus infection.
Journal of virology 2003;77(6):3531-41.
2002: Hsueh-Wei Chang; Shing M Lee; Steven Goodman; Gad Singer; Sarah K R Cho; Lori J Sokoll; Fredrick J Montz; Richard B S Roden; Zhen Zhang; Daniel W Chan; Robert J Kurman; Ie-Ming Shih
Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer.
Journal of the National Cancer Institute 2002;94(22):1697-703.
2001: Honami Naora; F J Montz; C Y Chai; Richard B S Roden
Aberrant expression of homeobox gene HOXA7 is associated with müllerian-like differentiation of epithelial ovarian tumors and the generation of a specific autologous antibody response.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(26):15209-14.
2001: Richard B S Roden; Patricia M Day; B K Bronzo; Wil Yutzy; Y Yang; Douglas Lowy; John T Schiller
Positively charged termini of the L2 minor capsid protein are necessary for papillomavirus infection.
Journal of virology 2001;75(21):10493-7.
2001: M M Okun; Patricia M Day; HL Greenstone; frank booy; Douglas Lowy; John T Schiller; Richard B S Roden
L1 interaction domains of papillomavirus l2 necessary for viral genome encapsidation.
Journal of virology 2001;75(9):4332-42.
2001: Honami Naora; Y Q Yang; F J Montz; Jeffrey D Seidman; Robert J Kurman; Richard B S Roden
A serologically identified tumor antigen encoded by a homeobox gene promotes growth of ovarian epithelial cells.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(7):4060-5.
2001: Clayton D Harro; Yuk-Ying S Pang; Richard B S Roden; Allan Hildesheim; Z Wang; M J Reynolds; T C Mast; R Robinson; Brian Murphy; Ruth A Karron; J Dillner; John T Schiller; Douglas Lowy
Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine.
Journal of the National Cancer Institute 2001;93(4):284-92.
2001: Wen-Fang Cheng; Chien-Fu Hung; Keng-Fu Hsu; Chee-Yin Chai; Liangmei He; Morris Ling; Leigh A Slater; Richard B S Roden; Tzyy-choou Wu
Enhancement of sindbis virus self-replicating RNA vaccine potency by targeting antigen to endosomal/lysosomal compartments.
Human gene therapy 2001;12(3):235-52.
2000: Morris Ling; M Kanayama; Richard B S Roden; Tzyy-choou Wu
Preventive and therapeutic vaccines for human papillomavirus-associated cervical cancers.
Journal of biomedical science 2000;7(5):341-56.
2000: Richard B S Roden; Wil Yutzy; R Fallon; S Inglis; Douglas Lowy; John T Schiller
Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes.
Virology 2000;270(2):254-7.
1999: Denise Nardelli-Haefliger; Richard B S Roden; Carole Balmelli; Alexandra Potts; J Schiller; Pierre De Grandi
Mucosal but not parenteral immunization with purified human papillomavirus type 16 virus-like particles induces neutralizing titers of antibodies throughout the estrous cycle of mice.
Journal of virology 1999;73(11):9609-13.
1998: Carole Balmelli; Richard B S Roden; Alexandra Potts; J Schiller; Pierre De Grandi; Denise Nardelli-Haefliger
Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions.
Journal of virology 1998;72(10):8220-9.
1998: frank booy; Richard B S Roden; HL Greenstone; John T Schiller; Benes Trus
Two antibodies that neutralize papillomavirus by different mechanisms show distinct binding patterns at 13 A resolution.
Journal of molecular biology 1998;281(1):95-106.
1998: HL Greenstone; JD Nieland; Karin E de Visser; ML De Bruijn; Reinhard Kirnbauer; Richard B S Roden; Douglas Lowy; W Martin Kast; John T Schiller
Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(4):1800-5.
1998: Patricia M Day; Richard B S Roden; Douglas Lowy; John T Schiller
The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains.
Journal of virology 1998;72(1):142-50.
1997: Richard B S Roden; Douglas Lowy; John T Schiller
Papillomavirus is resistant to desiccation.
The Journal of infectious diseases 1997;176(4):1076-9.
1997: Denise Nardelli-Haefliger; Richard B S Roden; Jalil Benyacoub; Roland Sahli; JP Kraehenbuhl; John T Schiller; P Lachat; Alexandra Potts; Pierre De Grandi
Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice.
Infection and immunity 1997;65(8):3328-36.
1997: Richard B S Roden; A Armstrong; P Haderer; Neil Christensen; NL Hubbert; Douglas Lowy; John T Schiller; Reinhard Kirnbauer
Characterization of a human papillomavirus type 16 variant-dependent neutralizing epitope.
Journal of virology 1997;71(8):6247-52.
1997: Benes Trus; Richard B S Roden; HL Greenstone; M Vrhel; John T Schiller; frank booy
Novel structural features of bovine papillomavirus capsid revealed by a three-dimensional reconstruction to 9 A resolution.
Nature structural biology 1997;4(5):413-20.
1996: Richard B S Roden; HL Greenstone; Reinhard Kirnbauer; frank booy; J Jessie; Douglas Lowy; John T Schiller
In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype.
Journal of virology 1996;70(9):5875-83.
1996: Richard B S Roden; N L Hubbert; Reinhard Kirnbauer; Neil Christensen; Douglas Lowy; John T Schiller
Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition.
Journal of virology 1996;70(5):3298-301.
1995: Richard B S Roden; N L Hubbert; Reinhard Kirnbauer; Françoise Breitburd; Douglas Lowy; John T Schiller
Papillomavirus L1 capsids agglutinate mouse erythrocytes through a proteinaceous receptor.
Journal of virology 1995;69(8):5147-51.
1994: Richard B S Roden; Reinhard Kirnbauer; A B Jenson; Douglas Lowy; John T Schiller
Interaction of papillomaviruses with the cell surface.
Journal of virology 1994;68(11):7260-6.
1994: Richard B S Roden; Eva M Weissinger; DW Henderson; frank booy; Reinhard Kirnbauer; J Frederic Mushinski; Douglas Lowy; John T Schiller
Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins.
Journal of virology 1994;68(11):7570-4.
1993: Reinhard Kirnbauer; J Taub; HL Greenstone; Richard B S Roden; M Dürst; L Gissmann; Douglas Lowy; John T Schiller
Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles.
Journal of virology 1993;67(12):6929-36.
1993: Richard B S Roden; Y Shachar-Hill; S C Cosulich; T R Hesketh; James C Metcalfe
A common requirement for p21c-ras function in the mitogenic signaling pathways of Swiss 3T3 fibroblasts.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1993;4(12):957-64.